-
EP1265616
European procedure
Extract from the Register of European Patents
EP About this file: EP1265616
| EP1265616 - HORMONE REPLACEMENT THERAPY USING A COMBINATION OF CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 23.03.2007 Database last updated on 08.04.2026 | Most recent event Tooltip | 21.12.2007 | Change - lapse in a contracting state State(s) deleted from list of lapses: IT | published on 23.01.2008 [2008/04] | Applicant(s) | For all designated states Wyeth Five Giralda Farms Madison, NJ 07940-0874 / US | [N/P] |
| Former [2002/51] | For all designated states Wyeth Five Giralda Farms Madison, New Jersey 07940-0874 / US | Inventor(s) | 01 /
PICKAR, James, H. 816 Crum Creek Road Springfield, PA 19064 / US | [2002/51] | Representative(s) | Mannion, Sally Kim Wyeth Pharmaceuticals Huntercombe Lane South Taplow Maidenhead Berkshire SL6 0PH / GB | [N/P] |
| Former [2002/51] | Mannion, Sally Kim, Dr. Wyeth Pharmaceuticals, Huntercombe Lane South, Taplow Maidenhead, Berkshire SL6 0PH / GB | Application number, filing date | 01923331.1 | 16.03.2001 | [2002/51] | WO2001US40302 | Priority number, date | US20000190630P | 20.03.2000 Original published format: US 190630 P | US20010268607P | 14.02.2001 Original published format: US 268607 P | [2002/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0170208 | Date: | 27.09.2001 | Language: | EN | [2001/39] | Type: | A2 Application without search report | No.: | EP1265616 | Date: | 18.12.2002 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.09.2001 takes the place of the publication of the European patent application. | [2002/51] | Type: | B1 Patent specification | No.: | EP1265616 | Date: | 17.05.2006 | Language: | EN | [2006/20] | Search report(s) | International search report - published on: | EP | 25.04.2002 | Classification | IPC: | A61K31/57, A61P5/30 | [2002/51] | CPC: |
A61K31/565 (EP,US);
A61K31/56 (KR);
A61K31/57 (EP,US);
A61P1/16 (EP);
A61P11/00 (EP);
A61P13/02 (EP);
A61P15/00 (EP);
A61P15/02 (EP);
A61P15/12 (EP);
A61P17/06 (EP);
A61P19/00 (EP);
A61P19/08 (EP);
A61P19/10 (EP);
A61P21/04 (EP);
A61P25/00 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/06 (EP);
A61P31/04 (EP);
A61P31/20 (EP);
A61P35/00 (EP);
A61P37/02 (EP);
A61P5/00 (EP);
A61P5/12 (EP);
A61P5/24 (EP);
A61P5/30 (EP);
| C-Set: |
A61K31/565, A61K2300/00 (US,EP);
A61K31/57, A61K2300/00 (US,EP);
A61K31/57, A61K31/565 (EP,US)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2002/51] | Extension states | AL | 02.09.2002 | LT | 02.09.2002 | LV | 02.09.2002 | MK | Not yet paid | RO | 02.09.2002 | SI | 02.09.2002 | Title | German: | HORMONERSATZTHERAPIE UNTER VERWENDUNG EINER KOMBINATIOIN VON KONJUGIERTEN OESTROGENEN UND MEDROXYPROGESTERON AZETAT | [2002/51] | English: | HORMONE REPLACEMENT THERAPY USING A COMBINATION OF CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | [2002/51] | French: | THERAPIE PAR REMPLACEMENT D'HORMONES UTILISANT UNE COMBINATION D'OESTROGENES CONJUGUES ET DE MEDROXYPROGESTERONE ACETATE | [2002/51] | Entry into regional phase | 02.09.2002 | National basic fee paid | 02.09.2002 | Designation fee(s) paid | 02.09.2002 | Examination fee paid | Examination procedure | 29.09.2001 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 02.09.2002 | Examination requested [2002/51] | 24.02.2004 | Despatch of a communication from the examining division (Time limit: M06) | 02.09.2004 | Reply to a communication from the examining division | 05.10.2005 | Communication of intention to grant the patent | 13.01.2006 | Fee for grant paid | 13.01.2006 | Fee for publishing/printing paid | Opposition(s) | 20.02.2007 | No opposition filed within time limit [2007/17] | Fees paid | Renewal fee | 05.03.2003 | Renewal fee patent year 03 | 04.03.2004 | Renewal fee patent year 04 | 04.03.2005 | Renewal fee patent year 05 | 06.03.2006 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2008/04] |
| Former [2007/36] | IT | 17.05.2006 | Cited in | International search | [X] B.M.WOLFE, M.W.HUFF: "Effects of continuous low-dosage hormonal replacement therapy on lipoprotein metabolism in postmenopausal women", METABOLISM CLINICAL & EXPERIMENTAL, vol. 44, no. 3, 1995, pages 410 - 417, XP001053539 [X] 1,2,4,6,7,9,11-15,19,20,22,25,26,40,41,43,45,46 * page 410 * DOI: http://dx.doi.org/10.1016/0026-0495(95)90175-2 | [X] H.SUMINO E.A.: "Serum level of vascular endothelial growth factor is decreased by hormone replacement therapy in postmenopausal women without hypercholesterolemia", ATHEROSCLEROSIS, vol. 148, no. 1, 2000, pages 189 - 195, XP001053480 [X] 1,2,6,9,13-15,19-22,25,26,40,41,45 * page 189 - page 190 * DOI: http://dx.doi.org/10.1016/S0021-9150(99)00262-2 | [X] G.G.GIRAUD E.A.: "Effects of estrogen and progestin on aortic size and compliance in postmanopausal women", AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol. 174, no. 6, 1996, pages 1708 - 1718, XP001053521 [X] 1,2,6,13,15,19-23,25,26,40,41,45 * page 1708 - page 1709 * DOI: http://dx.doi.org/10.1016/S0002-9378(96)70201-6 |